Senate approves postpartum-depression screening coverage; bill also restricts step-therapy for Medicaid patients

The Senate adopted legislation requiring coverage for postpartum-depression screening and restricting insurers’ use of step therapy for treatment when the condition is diagnosed in postpartum patients. Sponsors said screening and timely treatment can prevent severe maternal mental-health outcomes.

Why it matters: Maternal health was a recurring theme in the chamber. Sponsors noted Mississippi’s maternal-mortality context and said screening and removing insurer-imposed step-therapy barriers would improve timely access to appropriate medications and mental-health services.

What the bill does: The bill requires coverage for postpartum-depression screening and bars step-therapy protocols that would delay or require sequential medication trials for postpartum depression in covered populations. Sponsors told the Senate the change is consistent with similar legislation in neighboring states and on best-practice clinical guidance.

Questions on scope and coverage: Senators asked whether the screening would occur at the hospital and at the six-week postpartum visit; sponsors said screening would typically be offered in both settings and could be administered by clinicians and other licensed care professionals. Senators also asked about cost; the sponsor said Medicaid managed-care organizations already provide screening components and that the primary medications used in postpartum cases are low-cost drugs (floor cited examples of $4 and $10 medicines), but a full fiscal note was not on the floor.

Outcome: The committee substitute was adopted and the bill passed by use of the morning roll call.